Scotoma Reduction in AMD Patients Treated With Ranibizumab

Completed · Phase 1/Phase 2

Conditions studied: Macular Degeneration

In brief

This is a trial aimed at patients with advanced wet macular degeneration and macular scarring treated wiht intravitreal injections of Lucentis.

Key facts

Study ID

NCT00467935

Run by

Retina Research Foundation

People needed

20

Starts

2007-03-01

Expected to finish

2007-11-01

Last updated by the study team

2011-07-29

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• BCVA < 20/320
• Disciform macular degeneration wiht exudation

You may not qualify if…

• Non-amd CNV

Where it is running

• Retina Research Center — Slingerlands, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.